NCT06315257View on ClinicalTrials.gov

A Clinical Trial to Assess PVX7 Immunotherapy Regimens in Advanced Cervical Cancer Patients

PHASE1RecruitingINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

September 22, 2025

Primary Completion Date

April 30, 2028

Study Completion Date

October 31, 2029

Conditions
Cervical Cancer
Interventions
DRUG

PVX7

PVX7 Immunotherapy

Trial Locations (2)

21287

RECRUITING

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore

35233

RECRUITING

The University of Alabama at Birmingham, Birmingham

All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

OTHER

NCT06315257 - A Clinical Trial to Assess PVX7 Immunotherapy Regimens in Advanced Cervical Cancer Patients | Biotech Hunter | Biotech Hunter